Clinical Study
Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience
Table 3
Dosimetric estimates for kidney and bone marrow.
| | Mean | Median | SD | Range |
|
90Y-kidney dose (Gy/GBq) | | | 1.9 | 0.32–8.90 |
90Y-bone marrow dose (Gy/GBq) | | | 0.1 | 0.0047–0.51 |
177Lu-kidney dose (Gy/GBq) |
3.9 | | 0.3 | 0.05–1.47 |
177Lu-bone marrow dose (Gy/GBq) | | | 0.04 | 0.0163–0.256 |
|
|